Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH
Asian Pacific journal of cancer prevention : APJCP, 18(1), 17-21, 2017
Abstract
The polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility and a notable proportion of women of reproductive age are affected. It may constitute a risk factor for cancer development. Different factors could result in different manifestations and many of these are related to predispositions. It is essential to establish criteria to achieve an exact diagnosis of PCOS, especially among adolescent patients because of the overlap between features of PCO syndrome and physiological findings in puberty. Day by day the technology of ultrasonography is improving and accuracy is increasing, but remains dependent on the specific equipment available. Some factors are inter-related in determining PCOS prognosis. Serum AMH is synthesized by small antral follicles, which are precisely those seen on ultrasound and could help us to diagnose PCOS but there are many aspects that still require elucidation. In this mini- review we have attempted to identify some of these correlations.
Topics
Cite this article
Mohammad, M. B., & Seghinsara, A. M. (2017). Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH. *Asian Pacific journal of cancer prevention : APJCP*, *18*(1), 17-21. https://doi.org/10.22034/APJCP.2017.18.1.17
Mohammad MB, Seghinsara AM. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH. Asian Pac J Cancer Prev. 2017;18(1):17-21. doi:10.22034/APJCP.2017.18.1.17
Mohammad, Majid Bani, and Abbas Majdi Seghinsara. "Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH." *Asian Pacific journal of cancer prevention : APJCP*, vol. 18, no. 1, 2017, pp. 17-21.
Keywords
Polycystic Ovary Syndrome, anti-Müllerian Hormone, Diagnosis, Treatment